HHS/ASPR Biodefense + Bioterrorism Preparedness News

ASPR

The office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.

Biodefense Headlines – 13 July 2025

News Scan July 13, 2025

This week’s topics include cuts to CDC and USAID that threaten global biodefense, breakthrough vaccines for Nipah and CCHF, and confirmation of airborne H5N1 transmission in mammals. Also: Rwanda’s rapid…

ASPR

Chemical Threat Medical Countermeasure Development

BARDA Conducting Market Research on Ebola Medical Countermeasures

Emergent BioSolutions to Develop Viral Hemorrhagic Fever Therapeutics Under BARDA Contract

Elusys Delivers Anthrax Countermeasure Order, Gains Funding for Lyophilization Effort

HHS Releases 2016 PHEMCE Strategy and Implementation Plan

Health Canada Approves NDS for Botulinum Neurotoxin Countermeasure

CDC Awards Up to $1 Billion for BioThrax Deliveries to Strategic National Stockpile

Rick Bright Selected as New BARDA Director

DHS Assesses Tetracore’s Anthrax Lateral Flow Assay

U.S. Invests in Amgen, Sanofi Countermeasures for Radiological Incidents

BARDA Backs Biodosimetry Tests from MRIGlobal, DxTerity Diagnostics

NuThrax: HHS Backs Next-Gen Anthrax Vaccine with 198M Contract

Phase I Study Planned for Multivalent Vaccine to Combat Ebola, Marburg

Innovation Prize Competition for Antimicrobial Resistance Diagnostics

BARDA Backs OraSure’s Rapid Zika Diagnostic

BARDA Backs Antibody Therapy Against MERS Virus

HHS Funds Rapid, High-Capacity Zika Serological Diagnostic

HHS Backs Hologic’s Zika Blood Screening Test

Pfenex Anthrax Vaccine Shows Good Early Results

Single-Dose Anthrax Vaccine Nasal Spray Clinical Trial

Biodefense Headlines – 13 July 2025